RS

Ritu Singla

Active Director Director DIN 09061388
DIN 09061388 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Ritu Singla

Data last updated:

Ritu Singla is a Director at Adegen Pharma Private Limited (since 2021). The company operates in Pharma. Adegen Pharma Private Limited reported revenue of ₹1.37 Cr (FY 2024).

DIN 09061388
Primary Designation Director
Industry Pharma
First Appointment 22 Feb 2021
Oldest Company Age 6 yrs
Largest company Adegen Pharma Private Limited · ₹1.37 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adegen Pharma Private Limited U24304HR2020PTC085571
Director22 Feb 20212020₹1.37 Cr (FY 2024)Active

Board colleagues of Ritu Singla

NameDINCompanyDesignation
Pooja Singla09061156Adegen Pharma Private LimitedDirector
Sanjeev Kumar09075410Adegen Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adegen Pharma Private Limited
Premium access

Shareholding and investment profile for Ritu Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Singla

Ritu Singla currently holds 1 directorship: Adegen Pharma Private Limited (Director, since 22 Feb 2021, revenue ₹1.37 Cr (FY 2024)).

Ritu Singla was first appointed on 22 Feb 2021 as Director at Adegen Pharma Private Limited.

The current boards of Ritu Singla's companies include Pooja Singla (Adegen Pharma Private Limited), Sanjeev Kumar (Adegen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available